Overexpression of B7-H3 in CD14+ monocytes is associated with renal cell carcinoma progression

Medical Oncology

Volumn 31, Issue 12, 2014, Pages

  Li, Miao ^a   Zhang, Guangbo ^a   Zhang, Xuefeng ^a   Lv, Guanglin ^a   Wei, Xuedong ^a   Yuan, Hexing ^a   Hou, Jianquan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Angiogenesis; B7H3; CD14+ monocytes; Renal cell carcinoma

Indexed keywords

B7 H3; TUMOR MARKER; UNCLASSIFIED DRUG; B7 ANTIGEN; CD14 ANTIGEN; CD276 PROTEIN, HUMAN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER GROWTH; CD14+ MONOCYTE; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN EXPRESSION; STROMA; KIDNEY; KIDNEY TUMOR; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; B7 ANTIGENS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84919933828     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0349-1     Document Type: Article

References (27)

1. Izutsu T, Konda R, Sugimura J, Iwasaki K, Fujioka T. Brain-specific angiogenesis inhibitor 1 is a putative factor for inhibition of neovascular formation in renal cell carcinoma. J Urol. 2011;185:2353–8.
2. Cairns P. Renal cell carcinoma. Cancer Biomark. 2010;9:461–73.
3. Verheul HM, van Erp K, Homs MY, Yoon GS, van der Groep P, Rogers C, et al. The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. Urology. 2010;75:608–14.
4. Sharma SG, Aggarwal N, Gupta SD, Singh MK, Gupta R, Dinda AK. Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors. Int Urol Nephrol. 2011;43:125–9.
5. Chambers SE, O’Neill CL, O’Doherty TM, Medina RJ, Stitt AW. The role of immune-related myeloid cells in angiogenesis. Immunobiology. 2013;218:1370–5.
6. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, Fliser D, et al. SuperSAGE evidence for CD14 ++CD16 + monocytes as a third monocyte subset. Blood. 2011;118:e50–61.
7. Venneri MA, De Palma M, Ponzoni M, Pucci F, Scielzo C, Zonari E, et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood. 2007;109:5276–85.
8. Krenning G, van der Strate BW, Schipper M, Brouwer LA, Fernandes BC, van Luyn MJ, et al. Combined implantation of CD34 + and CD14 + cells increases neovascularization through amplified paracrine signalling. J Tissue Eng Regen Med. 2013;7:118–28.
9. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol. 2001;2:269–74.
10. Kraan J, van den Broek P, Verhoef C, Grunhagen DJ, Taal W, Gratama JW, et al. Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells. Br J Cancer. 2014;111:149–56.
11. Zang X, Sullivan PS, Soslow RA, Waitz R, Reuter VE, Wilton A, et al. Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod Pathol. 2010;23:1104–12.
12. Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, et al. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res. 2008;14:5150–7.
13. Yuan H, Wei X, Zhang G, Li C, Zhang X, Hou J. B7-H3 over expression in prostate cancer promotes tumor cell progression. J Urol. 2011;186:1093–9.
14. Ji J, Zhang G, Sun B, Yuan H, Huang Y, Zhang J, et al. The frequency of tumor-infiltrating Tie-2-expressing monocytes in renal cell carcinoma: its relationship to angiogenesis and progression. Urology. 2013;82:974–9.
15. Krenning G, Dankers PY, Jovanovic D, van Luyn MJ, Harmsen MC. Efficient differentiation of CD14 + monocytic cells into endothelial cells on degradable biomaterials. Biomaterials. 2007;28:1470–9.
16. Favre J, Terborg N, Horrevoets AJ. The diverse identity of angiogenic monocytes. Eur J Clin Invest. 2013;43:100–7.
17. Mayer A, Roch T, Kratz K, Lendlein A, Jung F. Pro-angiogenic CD14(++) CD16(+) CD163(+) monocytes accelerate the in vitro endothelialization of soft hydrophobic poly (n-butyl acrylate) networks. Acta Biomater. 2012;8:4253–9.
18. Khan B, Rangasamy S, McGuire PG, Howdieshell TR. The role of monocyte subsets in myocutaneous revascularization. J Surg Res. 2013;183:963–75.
19. Navarro A, Marin S, Riol N, Carbonell-Uberos F, Minana MD. Human adipose tissue-resident monocytes exhibit an endothelial-like phenotype and display angiogenic properties. Stem Cell Res Ther. 2014;5:50.
20. Wang L, Kang FB, Shan BE. B7-H3-mediated tumor immunology: friend or foe? Int J Cancer. 2014;134:2764–71.
21. Fauci JM, Straughn JJ, Ferrone S, Buchsbaum DJ. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer. Gynecol Oncol. 2012;127:420–5.
22. Liu Y, Vlatkovic L, Saeter T, Servoll E, Waaler G, Nesland JM, et al. Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population? Int J Urol. 2012;19:749–56.
23. Brunner A, Hinterholzer S, Riss P, Heinze G, Brustmann H. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis. Gynecol Oncol. 2012;124:105–11.
24. Qin X, Zhang H, Ye D, Dai B, Zhu Y, Shi G. B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma. Onco Targets Ther. 2013;6:1667–73.
25. Mesri M, Birse C, Heidbrink J, McKinnon K, Brand E, Bermingham CL, et al. Identification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues. PLoS One. 2013;8:e78885.
26. Jaipersad AS, Lip GY, Silverman S, Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol. 2014;63:1–11.
27. Ma L, Luo L, Qiao H, Dong X, Pan S, Jiang H, et al. Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy. J Hepatol. 2007;46:98–106.